Cargando…
Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci
Gram positive pathogens are a significant cause of healthcare-associated infections, with Staphylococci and Enterococci being the most prevalent ones. Vancomycin, a last resort glycopeptide, is used to fight these bacteria but the emergence of resistance against this drug leaves some patients with f...
Autores principales: | Baëtz, Benjamin, Boudrioua, Abdelhakim, Hartke, Axel, Giraud, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471638/ https://www.ncbi.nlm.nih.gov/pubmed/34572698 http://dx.doi.org/10.3390/antibiotics10091116 |
Ejemplares similares
-
Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014) -
Emergence of vancomycin-resistant enterococci.
por: Rice, L B
Publicado: (2001) -
Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
por: Kara, Ahu, et al.
Publicado: (2014) -
Gene Duplications in the Genomes of Staphylococci and Enterococci
por: Sanchez-Herrero, José Francisco, et al.
Publicado: (2020) -
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
por: Sader, Helio S, et al.
Publicado: (2007)